Platelet BioGenesis, Inc. — Form D

Platelet BioGenesis, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-28. The offering totals $1.5M, of which $1.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (17)

NameRoleLocation
Jonathan Erik ThonDirectorDorchester, MA
Peter Erik FinnExecutive OfficerNeedham, MA
Sven Erik KarlssonExecutive OfficerBoston, MA
Philip ReillyDirectorHingham, MA
Mark McDadeDirectorSouth San Francisco, CA
Richard MurrayDirectorSouth San Francisco, CA
Steven AltschulerDirectorWATERTOWN, MA
Steve AltschulerDirectorWatertown, MA
Peter FinnExecutive OfficerWatertown, MA
Jonathan ThonDirectorMalden, MA
Jonathan ThonExecutive OfficerMalden, MA
Sam RastyDirectorWatertown, MA
Sam RastyExecutive OfficerWatertown, MA
Chidozie UgwumbaDirectorWatertown, MA
Joseph ItalianoDirectorWatertown, MA
Sven KarlssonDirectorCAMBRIDGE, MA
Sven KarlssonExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2021-11-04D$35.4M$35.4M
2019-08-13D/A$26.4M$26.4M
2019-06-19D$11.4M$11.4M
2017-05-31D$10.0M$10.0M

More